INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

79,798 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HD
Hedigan DanielSee Remarks
FPHFive Point Holdings, LLC
Option exercise
M—
98.7K sh
Mar 9, 2026Mar 10, 2026
Page 1393 of 1995
← PrevNext →
traded Mar 9, 2026
+1d
SEC Form 4

Evidence

9
KL
Kalvaitis Jeanne LouiseEVP of Hospice Operations
EHABEnhabit, Inc.
Tax withholding
F$19K
1,365 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
LM
Leon Justin MSVP, CORPORATE DEVELOPMENT
ATNIATN International, Inc.
Tax withholding
F$34K
1,424 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
KL
Kalvaitis Jeanne LouiseEVP of Hospice Operations
EHABEnhabit, Inc.
Tax withholding
F$11K
835 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$1,010
22 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
8,333 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
JM
Jansen John MDirector
OKLOOklo Inc.
Option exercise
M—
16.9K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
2,625 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$314K
7,361 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M—
8,333 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
SN
Savchuk NikolayDirector, Chief Operating Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
96.9K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
PD
Pauza Charles DavidChief Science Officer Virology
TRAWTraws Pharma, Inc.
Grant or award
A—
118.4K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
BW
Bradshaw WenkaiCAO & SVP Corporate Controller
TEADTeads Holding Co.
Tax withholding
F$365
434 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
WD
Wichman Gordon DouglasExecutive Vice President
AAONAAON, INC.
Tax withholding
F$9,010
102 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
KJ
Kiviat JasonChief Financial Officer
TEADTeads Holding Co.
Tax withholding
F$6,556
7,805 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
OD
Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER
FNKOFunko, Inc.
Option exercise
M—
4,700 sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
KJ
Kiviat JasonChief Financial Officer
TEADTeads Holding Co.
Tax withholding
F$1,788
2,129 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
SJ
Samuelson JonasDirector
PRGOPERRIGO Co plc
Tax withholding
F$19K
1,748 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$658K
15.7K sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

9
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
3,750 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
DD
DeLucia DavidChief Financial Officer
KYNBKYNTRA BIO, INC.
Tax withholding
F$410
60 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
20.0K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
RR
Redfield RobertChief Medical Officer
TRAWTraws Pharma, Inc.
Grant or award
A—
108.9K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
NA
Narayanan ArunChief Executive Officer
STEMSTEM, INC.
Option exercise
M—
5,625 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Option exercise
M—
896 sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

9
DN
Davies NicoleEVP, Corporate Development
FLRFLUOR CORP
Tax withholding
F$17K
377 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

9
LM
Leon Justin MSVP, CORPORATE DEVELOPMENT
ATNIATN International, Inc.
Tax withholding
F$15K
613 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
DH
Dhruv Anuj HasitEVP and CFO
WFRDWeatherford International plc
Grant or award
A—
8,256 sh
Mar 7, 2026Mar 10, 2026
traded Mar 7, 2026
+3dSEC Form 4

Evidence

9
AD
Ackley DavidEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$1,286
28 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

8
FC
Fruge Mary CelesteVP, General Counsel
NPKINPK International Inc.
Open-market sale · 10b5-1 plan
SELL$149K
11.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

7
WM
Wittmann MichaelChief Operating Officer
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
25.0K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
29.9K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$110K
2,505 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$181K
4,441 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

5
AE
Alexander Michael E.GROUP PRESIDENT
FLRFLUOR CORP
Tax withholding
F$31K
678 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Option exercise
M—
750 sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$1,185
463 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
MG
Mcconnell Jill G.Chief Financial Officer
FTREFortrea Holdings Inc.
Grant or award
A—
66.7K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

5
TK
Tobler KimSee Remarks
FPHFive Point Holdings, LLC
Option exercise
M—
36.4K sh
Mar 8, 2026Mar 10, 2026
traded Mar 8, 2026
+2dSEC Form 4

Evidence

5
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Option exercise
M—
2,344 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence